Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The Problem with the Share Price/bush
14
Feb 14, 2011 06:07PM
9
Feb 14, 2011 06:14PM
11
Feb 14, 2011 06:21PM
17
Feb 14, 2011 06:26PM
4
Feb 14, 2011 08:07PM
4
Feb 14, 2011 08:17PM
10
Feb 14, 2011 08:42PM
7
Feb 14, 2011 08:59PM
3
Feb 14, 2011 09:14PM

Feb 14, 2011 09:18PM
10
Feb 14, 2011 09:34PM
11
Feb 14, 2011 09:52PM
7
Feb 14, 2011 10:02PM
8
Feb 15, 2011 09:02AM
22
Feb 15, 2011 09:19AM

that is just not true. examination of our sec financials would point one to examine why the revenue picture has decreased and why are treasury has decreased. that examination would point to the ones in charge and that is the BOD. I would agree that in most companies a BOD is not the main focus....but PTSC is really just a BOD. PTSC does not make a product so PTSC's growth engine is the revenues received from licenses and the management of those license revenues. If the new investors concern is profitablity then what would your conclusion be as to why there is no profitability? posts on a message board?

teremoto

10
Feb 15, 2011 01:37PM
Share
New Message
Please login to post a reply